Chemoimmune Prophylaxis of Superficial Bladder Cancer
Author:
Affiliation:
1. From the Departments of Urology, University Hospital, Bonn and St. Josef Hospital, Troisdorf, West Germany
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference36 articles.
1. Comparison of placebo;Byar,1977
2. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading;Gilbert;J. Urol.,1978
3. Benign papilloma or papillary carcinoma of the bladder?;Greene;J. Urol.,1973
4. Rezidivhäufigkeit und Tumorprogression superficialer Harnblasenkarzinome;Rübben;Urologe A,1981
5. Changes in grade and stage of recurrent bladder tumors;Barnes;J. Urol.,1977
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches;The Journal of Pathology;2019-06-24
2. Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma;Clinical Rheumatology;2004-12-01
3. Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors;Anti-Cancer Drugs;1994-06
4. Long-term BCG immune therapy of superficial bladder tumours;International Urology and Nephrology;1992-03
5. The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer;International Urology and Nephrology;1991-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3